rs377047279
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_197975.3(BTNL3):c.161G>A(p.Arg54Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000786 in 1,463,006 control chromosomes in the GnomAD database, including 27 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R54P) has been classified as Uncertain significance.
Frequency
Consequence
NM_197975.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000515 AC: 7AN: 136048Hom.: 2 Cov.: 24
GnomAD3 exomes AF: 0.0000479 AC: 11AN: 229432Hom.: 3 AF XY: 0.0000400 AC XY: 5AN XY: 124876
GnomAD4 exome AF: 0.0000814 AC: 108AN: 1326958Hom.: 25 Cov.: 31 AF XY: 0.0000922 AC XY: 61AN XY: 661620
GnomAD4 genome AF: 0.0000515 AC: 7AN: 136048Hom.: 2 Cov.: 24 AF XY: 0.0000454 AC XY: 3AN XY: 66094
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.161G>A (p.R54Q) alteration is located in exon 2 (coding exon 2) of the BTNL3 gene. This alteration results from a G to A substitution at nucleotide position 161, causing the arginine (R) at amino acid position 54 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at